Clinical Trials
22 trialsThe Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML
LanZhou University
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
PETHEMA Foundation
PALG-AML1/2016
Polish Adult Leukemia Group
IA14 Induction in Young Acute Myeloid Leukemia
Peking Union Medical College Hospital
PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years
PETHEMA Foundation
Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy
Chinese PLA General Hospital
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
The First Affiliated Hospital of Soochow University
HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients
Nanfang Hospital, Southern Medical University
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia
Guangdong Provincial People's Hospital
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia
National Research Center for Hematology, Russia
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
AML-14A
European Organisation for Research and Treatment of Cancer - EORTC
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
University Hospital Muenster
CIARA
Hannover Medical School
AIvsAD
Cooperative Study Group A for Hematology
Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
Samsung Medical Center
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Efficacy of G-CSF-Priming in Elderly AML Patients
Johann Wolfgang Goethe University Hospital